Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55,482,166
-
Number of holders
-
132
-
Total 13F shares, excl. options
-
35,559,200
-
Shares change
-
+8,627,896
-
Total reported value, excl. options
-
$331,104,508
-
Value change
-
+$80,441,114
-
Put/Call ratio
-
178%
-
Number of buys
-
89
-
Number of sells
-
35
-
Price
-
$9.31
Institutional Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q1 2024
As of 31 Mar 2024 Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) had 132 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 35,559,200 shares of stock of the company.
Largest 10 holders included ARMISTICE CAPITAL, LLC, BlackRock Inc., EcoR1 Capital, LLC, VANGUARD GROUP INC, FARALLON CAPITAL MANAGEMENT LLC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, Erste Asset Management GmbH, PRICE T ROWE ASSOCIATES INC /MD/, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 132 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.